Neuroprotective Effects of Diets Containing Olive Oil and DHA/EPA in a Mouse Model of Cerebral Ischemia

Nutrients. 2019 May 18;11(5):1109. doi: 10.3390/nu11051109.

Abstract

Stroke is one of the leading causes of death worldwide and while there is increasing evidence that a Mediterranean diet might decrease the risk of a stroke, the effects of dietary fat composition on stroke outcomes have not been fully explored. We hypothesize that the brain damage provoked by a stroke would be different depending on the source of dietary fat. To test this, male C57BL/6J mice were fed for 4 weeks with a standard low-fat diet (LFD), a high-fat diet (HFD) rich in saturated fatty acids (HFD-SFA), an HFD containing monounsaturated fatty acids (MUFAs) from olive oil (HFD-OO), or an HFD containing MUFAs from olive oil plus polyunsaturated fatty acids (PUFAs) docosahexaenoic acid/eicosapentaenoic acid (DHA/EPA) (HFD-OO-ω3). These mice were then subjected to transient middle cerebral artery occlusion (tMCAo). Behavioural tests and histological analyses were performed 24 and/or 48 h after tMCAo in order to elucidate the impact of these diets with different fatty acid profiles on the ischemic lesion and on neurological functions. Mice fed with HFD-OO-ω3 displayed better histological outcomes after cerebral ischemia than mice that received an HFD-SFA or LFD. Furthermore, PUFA- and MUFA-enriched diets improved the motor function and neurological performance of ischemic mice relative to those fed with an LFD or HFD-SFA. These findings support the use of DHA/EPA-omega-3-fatty acid supplementation and olive oil as dietary source of MUFAs in order to reduce the damage and protect the brain when a stroke occurs.

Keywords: DHA; EPA; MUFA; PUFA; SFA; behaviour; cerebral ischemia; middle cerebral artery occlusion (MCAo); neurological function; neuroprotection; olive oil; omega-3 fatty acids; stroke.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Behavior, Animal
  • Brain Ischemia / drug therapy*
  • Diet, High-Fat / adverse effects
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / pharmacology*
  • Eating
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / pharmacology*
  • Gait
  • Gene Expression Regulation, Enzymologic / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Cerebral Artery
  • Olive Oil / administration & dosage
  • Olive Oil / pharmacology*
  • Weight Loss / drug effects

Substances

  • Antioxidants
  • Olive Oil
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid